Dianabol or anadrol for a first cycle?

Dianabol, without hesitation. The hepatic profile remains aggressive but reproducible, the estrogenic effect manages with a standard AI (anastrozole or exemestane), and the gains/tolerance curve is more predictable. Anadrol, despite its superior gains, requires fine knowledge of one's own hepatic and estrogenic tolerance (impossible to acquire on a first cycle). Start at 20-25 mg/d of dianabol to assess tolerance, increase to 30 mg/d if all goes well at W2.

Why does anadrol cause gynecomastia despite non-aromatization?

Oxymetholone has intrinsic estrogenic activity through direct interaction with the estrogen receptor, independent of aromatization (Kicman 2008). That is why an AI alone is not enough: it cannot block an absent aromatization. Treatment of anadrol gyno goes through a SERM (nolvadex 20-40 mg/d) which blocks the receptor directly. Many users prophylactically combine nolvadex 10 mg/d from D1 of an anadrol cycle.

How much realistic gains with dianabol?

Over 4-6 weeks at 30 mg/d as kickstart of a 500 mg/week testo cycle: +4 to +6 kg of raw mass, of which 30-50% is water retention that leaves on cessation and with AI. Retained net gains at 12 weeks post-PCT: ~+2 to +3 kg of real muscle attributable to dianabol alone, the rest coming from testo. Impressive strength effect from W2 (the 'pop' feeling users describe). Visually very fast but not durable without maintenance.

Which AI to choose with dianabol?

The methylestradiol from dianabol aromatization is partially resistant to anastrozole. Exemestane (Aromasin) 12.5 mg EOD is more effective because it inhibits aromatase irreversibly (suicide enzyme), and its metabolite has slight androgenic activity. If gynecomastia already established, add nolvadex 20 mg/d. Estradiol monitoring at W2 and W4 to titrate.

Is anadrol really more potent than testosterone?

Over the first 3-4 weeks window, yes: the combination of water retention + protein synthesis + anti-catabolic effect generates faster gains than any testo ester alone. But the effect plateaus quickly (protein synthesis saturates beyond certain receptor occupancy), and hepatic tolerance imposes stopping at 4 weeks. Over a complete 12-16 week cycle, testosterone alone at 500 mg/week produces superior net gains than an anadrol-only cycle, because it can be maintained throughout the cycle.

Hepatoprotectors: are they enough under dianabol or anadrol?

No. TUDCA 500 mg, NAC 600 mg × 2, and milk thistle can attenuate transaminase elevation and promote hepatocyte regeneration, but do not prevent cholestasis or hepatic peliosis at pharmacological doses. Biological monitoring remains essential: ALT, AST, GGT, total and direct bilirubin at W0, W2, W4, W6 (anadrol) or W0, W4, W8 (dianabol). Any ALT elevation > 3× or elevated direct bilirubin requires immediate stop.

What break after a dianabol or anadrol cycle?

Minimum 8 weeks strict hepatic break without any 17α-alkylated drug. Hepatocyte regeneration is rapid (at 2-3 weeks transaminases return to normal in most), but complete resolution of cellular micro-lesions takes longer. Resuming any other oral before 8 weeks accumulates damage. Take advantage of the break to restart the HPG axis via clean PCT (clomid + nolvadex 4-6 weeks, hCG as bridge per Rahnema 2014). Resume a cycle only after hepatic panel back to normal.

Does anadrol cause libido drop?

Yes, paradoxically for such an anabolic compound. Two mechanisms: (1) rapid and deep HPG axis suppression from week 2 — endogenous testosterone collapses while oxymetholone does not ensure complete androgenic role (low androgen receptor affinity vs its anabolic potency); (2) the direct estrogenic effect can functionally raise estrogenic activity without raising measurable serum E2. The workaround: always pair with a testosterone base ≥ 300 mg/week, and consider a prophylactic SERM if libido drops despite testo (sign of direct estrogenic effect requiring nolvadex).

Dianabol vs Anadrol: complete comparison (mass orals, potency, profile)

Critère	dianabol	anadrol
Anabolic/androgenic ratio	90-210:40-60	320:45
Half-life	~4-6 h	~9 h
Hepatotoxicity	High (17α-alkylated)	Very high (17α-alkylated)
Aromatization	Yes (methylestradiol)	No, but indirect estrogenic effect
HPG axis suppression	Strong	Very strong
Typical dose	20-40 mg/d	50-100 mg/d
Gains in 4-6 wk	4-6 kg	6-10 kg
Water retention	Marked	Very marked

Quand choisir dianabol

Dianabol (methandrostenolone) is the historical mass oral, created in the 1950s and still used today as a classic kickstart of an injectable cycle. Choose it for a first oral mass cycle or as priming block of a long testo cycle: Hartgens 2004 documents that its gains/time curve is very rapid (visible at D7-D10), thanks to marked aromatization (the methylestradiol metabolite contributes to water retention and visible muscular swelling) and rapid stimulation of muscular protein synthesis. Typical dose 25-30 mg/d × 4-6 weeks as kickstart of a testo enanthate cycle, split into 2-3 daily intakes (half-life ~5 h). Moderate androgenic profile: acne and hair loss possible in users predisposed to androgenetic alopecia. Major side effects to anticipate (Kicman 2008, Niedfeldt 2018): abundant water retention, dose-dependent hypertension (Smit 2022: high BP in 60% of dianabol-loaded users), systematic but reversible ALT/AST elevation on cessation, gynecomastia possible if AI insufficient — the methylestradiol from aromatization is partially resistant to anastrozole, so prefer exemestane or letrozole. Inadequate for users seeking 'clean' gains: half of the visible kilos leave on cessation with the drop of water retention.

Quand choisir anadrol

Anadrol (oxymetholone) is the most potent oral compound available in terms of raw mass. Hengge 2003 demonstrated in an RCT in HIV-wasting patients that 150 mg/d × 16 weeks produce +8.2 kg lean mass vs +0.9 kg under placebo — the highest amplitude ever documented for an oral AAS in controlled clinical trial. Choose it when you want maximum kickstart over 3-4 weeks before a long testosterone ester takes over, or mid-cycle to break through a plateau. Reserved for experienced users having done 2-3 cycles: very high hepatotoxic profile (Niedfeldt 2018: cases of intrahepatic cholestasis and hepatic peliosis documented at 100 mg/d × 8 weeks), indirect estrogenic effects despite no aromatization. Oxymetholone interacts directly with the muscular and mammary estrogen receptor — gynecomastia can appear without elevated estradiol, and an AI alone (anastrozole, letrozole) is totally ineffective. The workaround: SERM (nolvadex 20-40 mg/d) in parallel, and quick stop if symptoms. Sometimes unmanageable BP even under antihypertensive, and psychological effects (irritability, aggression, post-cycle anhedonia) reported in ~30% of users (Pope 2014). Typical dose 50-75 mg/d × 3-4 weeks maximum, with minimum 8-week hepatic break before any other oral. Risk/benefit ratio unfavorable for non-competitors: prefer dianabol for recreational use.

Combinaison ?

The dianabol + anadrol combo is strictly inadvisable: stacking two 17α-alkylated drugs at pharmacological doses doubles hepatic load without significant anabolic benefit (protein synthesis saturates at an androgen receptor occupancy threshold). If you want both benefits, structure in sequence: anadrol 50 mg/d × 3 weeks (W1-W3) as super-kickstart, then 2-week break, then dianabol 25 mg/d × 4 weeks (W6-W9) on a 12-week testo cycle. Always on strong testosterone base (400-500 mg/week) to ensure androgenic function. AI from start (exemestane 12.5 mg EOD preferred to manage anadrol's direct estrogenic effect). Monitoring ALT/AST, bilirubin, weekly BP, lipids every 4 weeks. Hepatoprotectors (TUDCA 500 mg, NAC 1200 mg) recommended. Several hepatologists consider this sequential combination remains risky despite the breaks. Sample timeline if sequential approach attempted (14-week cycle): W0 baseline complete panel + ECG if > 35y, W1 anadrol 50 mg/d start, W2 ALT/AST + BP, W3 mid-anadrol panel, W4 anadrol stop, W5-W6 hepatic break with weekly ALT/AST, W7 ALT/AST normal? then dianabol 25 mg/d, W9 ALT/AST + lipids + BP, W11 dianabol stop, W14 last injection, W17 PCT start. Sleep quality consideration: anadrol commonly disrupts sleep via direct estrogenic effect causing night sweats and vivid dreams — improves on cessation. Practical anti-gyno strategy: prophylactic nolvadex 10 mg/d from D1 of anadrol block is recommended by experienced users to avoid acute mid-cycle gyno onset, which can require multi-week treatment to reverse.

FAQ

Dianabol or anadrol for a first cycle?: Dianabol, without hesitation. The hepatic profile remains aggressive but reproducible, the estrogenic effect manages with a standard AI (anastrozole or exemestane), and the gains/tolerance curve is more predictable. Anadrol, despite its superior gains, requires fine knowledge of one's own hepatic and estrogenic tolerance (impossible to acquire on a first cycle). Start at 20-25 mg/d of dianabol to assess tolerance, increase to 30 mg/d if all goes well at W2.
Why does anadrol cause gynecomastia despite non-aromatization?: Oxymetholone has intrinsic estrogenic activity through direct interaction with the estrogen receptor, independent of aromatization (Kicman 2008). That is why an AI alone is not enough: it cannot block an absent aromatization. Treatment of anadrol gyno goes through a SERM (nolvadex 20-40 mg/d) which blocks the receptor directly. Many users prophylactically combine nolvadex 10 mg/d from D1 of an anadrol cycle.
How much realistic gains with dianabol?: Over 4-6 weeks at 30 mg/d as kickstart of a 500 mg/week testo cycle: +4 to +6 kg of raw mass, of which 30-50% is water retention that leaves on cessation and with AI. Retained net gains at 12 weeks post-PCT: ~+2 to +3 kg of real muscle attributable to dianabol alone, the rest coming from testo. Impressive strength effect from W2 (the 'pop' feeling users describe). Visually very fast but not durable without maintenance.
Which AI to choose with dianabol?: The methylestradiol from dianabol aromatization is partially resistant to anastrozole. Exemestane (Aromasin) 12.5 mg EOD is more effective because it inhibits aromatase irreversibly (suicide enzyme), and its metabolite has slight androgenic activity. If gynecomastia already established, add nolvadex 20 mg/d. Estradiol monitoring at W2 and W4 to titrate.
Is anadrol really more potent than testosterone?: Over the first 3-4 weeks window, yes: the combination of water retention + protein synthesis + anti-catabolic effect generates faster gains than any testo ester alone. But the effect plateaus quickly (protein synthesis saturates beyond certain receptor occupancy), and hepatic tolerance imposes stopping at 4 weeks. Over a complete 12-16 week cycle, testosterone alone at 500 mg/week produces superior net gains than an anadrol-only cycle, because it can be maintained throughout the cycle.
Hepatoprotectors: are they enough under dianabol or anadrol?: No. TUDCA 500 mg, NAC 600 mg × 2, and milk thistle can attenuate transaminase elevation and promote hepatocyte regeneration, but do not prevent cholestasis or hepatic peliosis at pharmacological doses. Biological monitoring remains essential: ALT, AST, GGT, total and direct bilirubin at W0, W2, W4, W6 (anadrol) or W0, W4, W8 (dianabol). Any ALT elevation > 3× or elevated direct bilirubin requires immediate stop.
What break after a dianabol or anadrol cycle?: Minimum 8 weeks strict hepatic break without any 17α-alkylated drug. Hepatocyte regeneration is rapid (at 2-3 weeks transaminases return to normal in most), but complete resolution of cellular micro-lesions takes longer. Resuming any other oral before 8 weeks accumulates damage. Take advantage of the break to restart the HPG axis via clean PCT (clomid + nolvadex 4-6 weeks, hCG as bridge per Rahnema 2014). Resume a cycle only after hepatic panel back to normal.
Does anadrol cause libido drop?: Yes, paradoxically for such an anabolic compound. Two mechanisms: (1) rapid and deep HPG axis suppression from week 2 — endogenous testosterone collapses while oxymetholone does not ensure complete androgenic role (low androgen receptor affinity vs its anabolic potency); (2) the direct estrogenic effect can functionally raise estrogenic activity without raising measurable serum E2. The workaround: always pair with a testosterone base ≥ 300 mg/week, and consider a prophylactic SERM if libido drops despite testo (sign of direct estrogenic effect requiring nolvadex).

Dianabol vs Anadrol: complete comparison (mass orals, potency, profile)

Critère	dianabol	anadrol
Anabolic/androgenic ratio	90-210:40-60	320:45
Half-life	~4-6 h	~9 h
Hepatotoxicity	High (17α-alkylated)	Very high (17α-alkylated)
Aromatization	Yes (methylestradiol)	No, but indirect estrogenic effect
HPG axis suppression	Strong	Very strong
Typical dose	20-40 mg/d	50-100 mg/d
Gains in 4-6 wk	4-6 kg	6-10 kg
Water retention	Marked	Very marked

Quand choisir dianabol

Quand choisir anadrol

Combinaison ?

FAQ

Dianabol or anadrol for a first cycle?: Dianabol, without hesitation. The hepatic profile remains aggressive but reproducible, the estrogenic effect manages with a standard AI (anastrozole or exemestane), and the gains/tolerance curve is more predictable. Anadrol, despite its superior gains, requires fine knowledge of one's own hepatic and estrogenic tolerance (impossible to acquire on a first cycle). Start at 20-25 mg/d of dianabol to assess tolerance, increase to 30 mg/d if all goes well at W2.
Why does anadrol cause gynecomastia despite non-aromatization?: Oxymetholone has intrinsic estrogenic activity through direct interaction with the estrogen receptor, independent of aromatization (Kicman 2008). That is why an AI alone is not enough: it cannot block an absent aromatization. Treatment of anadrol gyno goes through a SERM (nolvadex 20-40 mg/d) which blocks the receptor directly. Many users prophylactically combine nolvadex 10 mg/d from D1 of an anadrol cycle.
How much realistic gains with dianabol?: Over 4-6 weeks at 30 mg/d as kickstart of a 500 mg/week testo cycle: +4 to +6 kg of raw mass, of which 30-50% is water retention that leaves on cessation and with AI. Retained net gains at 12 weeks post-PCT: ~+2 to +3 kg of real muscle attributable to dianabol alone, the rest coming from testo. Impressive strength effect from W2 (the 'pop' feeling users describe). Visually very fast but not durable without maintenance.
Which AI to choose with dianabol?: The methylestradiol from dianabol aromatization is partially resistant to anastrozole. Exemestane (Aromasin) 12.5 mg EOD is more effective because it inhibits aromatase irreversibly (suicide enzyme), and its metabolite has slight androgenic activity. If gynecomastia already established, add nolvadex 20 mg/d. Estradiol monitoring at W2 and W4 to titrate.
Is anadrol really more potent than testosterone?: Over the first 3-4 weeks window, yes: the combination of water retention + protein synthesis + anti-catabolic effect generates faster gains than any testo ester alone. But the effect plateaus quickly (protein synthesis saturates beyond certain receptor occupancy), and hepatic tolerance imposes stopping at 4 weeks. Over a complete 12-16 week cycle, testosterone alone at 500 mg/week produces superior net gains than an anadrol-only cycle, because it can be maintained throughout the cycle.
Hepatoprotectors: are they enough under dianabol or anadrol?: No. TUDCA 500 mg, NAC 600 mg × 2, and milk thistle can attenuate transaminase elevation and promote hepatocyte regeneration, but do not prevent cholestasis or hepatic peliosis at pharmacological doses. Biological monitoring remains essential: ALT, AST, GGT, total and direct bilirubin at W0, W2, W4, W6 (anadrol) or W0, W4, W8 (dianabol). Any ALT elevation > 3× or elevated direct bilirubin requires immediate stop.
What break after a dianabol or anadrol cycle?: Minimum 8 weeks strict hepatic break without any 17α-alkylated drug. Hepatocyte regeneration is rapid (at 2-3 weeks transaminases return to normal in most), but complete resolution of cellular micro-lesions takes longer. Resuming any other oral before 8 weeks accumulates damage. Take advantage of the break to restart the HPG axis via clean PCT (clomid + nolvadex 4-6 weeks, hCG as bridge per Rahnema 2014). Resume a cycle only after hepatic panel back to normal.
Does anadrol cause libido drop?: Yes, paradoxically for such an anabolic compound. Two mechanisms: (1) rapid and deep HPG axis suppression from week 2 — endogenous testosterone collapses while oxymetholone does not ensure complete androgenic role (low androgen receptor affinity vs its anabolic potency); (2) the direct estrogenic effect can functionally raise estrogenic activity without raising measurable serum E2. The workaround: always pair with a testosterone base ≥ 300 mg/week, and consider a prophylactic SERM if libido drops despite testo (sign of direct estrogenic effect requiring nolvadex).